The invention
Platform for administration of lutetium-177 DOTATOC peptide receptor radionuclide therapy
M: Medicine – Surgery – Orthopaedics – Material for disabled
Informations
- Stand number
- B75
- Exhibition class
- M: Medicine – Surgery – Orthopaedics – Material for disabled
- Technical description
- Development of safe and effective platform for administration of lutetium-177 DOTATOC peptide receptor radionuclide therapy for neuroendocrine tumours or other tumours highly expressing somatostatin receptors.
- Simplified description
- We are developing a safe and effective treatment for certain cancers using targeted radiation therapy. This approach delivers lutetium-177 DOTATOC directly to tumors with specific receptors, helping destroy cancer cells while sparing healthy tissue.
Inventors
Chi Ang Nelson TO
inventor 3727293071_3908
Kam-Man TAM
inventor 3727293071_3906
Victor Ho-Fun LEE
inventor 3727293071_3903
The University of Hong Kong
inventor 3727293071_3106
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.